One of the biochemical pathways affected by aging in all organisms is protein synthesis. Previous reports from our laboratory have indicated that the elongation step is specially affected by aging as a consequence of alterations in elongation factor-2 (eEF-2). In the present work, we studied in vitro the effectiveness of several individual nutritional antioxidants in protecting the levels of hepatic eEF-2 subjected to oxidative stress induced by cumene hydroperoxide. The in vitro system employed consisted of rat liver homogenates treated with cumene hydroperoxide. The antioxidants used in this study were lipoic acid, coenzyme Q10, tethrahydrofolic acid, and N-tert-butyl-alpha-phenylnitrone. The results indicate that the antioxidants have different capacities to prevent eEF-2 loss, folic acid being the most effective. A comparison between the antioxidants used and their potential pro-oxidant activity is also discussed, on the basis of the oxidative stress parameters measured.
Aging can be defined as a loss of the normal physiological functions of an organism, being a consequence of endogenous and exogenous factors. These factors affect all cellular processes and tissues directly or indirectly. One of the biochemical pathways affected by aging in all organisms is protein synthesis, [1] [2] [3] which is essential for the maintenance of cellular homeostasis. In old animals, protein synthesis is inhibited by about 60-80%. 4) There is no clear consensus as to the mechanism underlying this decline with age, because protein synthesis is a complex process requiring the participation of many molecules. Previous reports from our laboratory have indicated that the elongation step is specially affected by aging. 5) This delay appears to be related to alterations in elongation factor-2 (eEF2). eEF2 has an essential role in protein synthesis, where it catalyzes the ribosomal translocation reaction, resulting in the movement of ribosomes along the mRNA. 6) This protein is regulated by several mechanisms, which suggests that it is involved in other biochemical reactions besides translation. 7) eEF-2 is particularly sensitive to the increased oxidative stress that occurs during aging. With age, this protein loses activity, displays a greater level of oxidation in its molecule, and is fragmented. 5) Oxidative modifications of eEF-2 are involved in physiological alterations in old animals such as decreases in the amounts of mineral corticoids receptors. 8) These molecular changes in eEF-2 observed during aging are also produced when treating young animals with oxidant compounds, 8) but not all the oxidants affect eEF-2. Only compounds that increase lipid peroxidation, such as cumene hydroperoxide (CH) and t-butyl-hydroperoxide, affect eEF-2.
9,10) Hence, it has been suggested that eEF-2 and consequently protein synthesis are mainly affected by lipid peroxidation processes.
Because the consequences of slower rates of protein synthesis are manifold in the context of aging and agerelated diseases, is interesting to establish interventions that might slow the effects of oxidative stress on translation. In this paper, we focus on antioxidants. Antioxidants consist of a few enzymes and several nutrients that protect key cell components from damage by neutralizing free radicals. 11, 12) However, antioxidants do not always reach all body and cell compartments. In addition, previous work by our laboratory has indicated that antioxidants protect only certain pathways from the effects of oxidation. Thus, proteomic techniques reveal that folic acid protects the alteration of only a few proteins damaged by administration of ethanol, including eEF-2, 13) which suggests that the role of antioxidants is specific rather than indiscriminate.
Considering the importance of the translation process in cell maintenance and metabolism and the specific effects of antioxidants on biochemical pathways, in the present work we studied in vitro the effectiveness of several individual antioxidants in protecting hepatic eEF-2 subjected to oxidative stress. The antioxidants used in this study were lipoic acid (LA), coenzyme Q10 (CoQ10), tethrahydrofolic acid (THF), and N-tertbutyl-alpha-phenylnitrone (PBN). Oxidative stress was induced by treating liver homogenates with CH, a compound used experimentally to induce lipid peroxidation. The homogenates were also pre-treated with various amounts of antioxidants, and levels of eEF-2 were determined to test whether all the antioxidants had the same capacity to protect eEF-2 from damage caused by CH. Markers of oxidative damage to lipids and proteins were also measured.
Materials and Methods
Animals. Male 3-month-old-Wistar rats weighing 250-300 g were used. The rats were maintained under automatically controlled temperature (22-23 C) and under a 12-h light-dark cycle. Animal care complied with the ''Guide for the Care and Use of Laboratory Animals'' (National Academy Press, Washington, DC, 1996).
Tissue samples. The rats were decapitated and liver samples were stored at À80 C until biochemical determinations were performed. Hepatic tissues were homogenized in 10 mM N-2-hydroxyethylpiperazine-N 0 -2-ethanesulfonic acid, pH 7.0, 0.2 mM phenylmethyl sulfonyl fluoride (PMSF) buffer. The homogenate was centrifuged at 800 Â g for 10 min, and the supernatant obtained was centrifuged 15;000 Â g for 20 min. The liver homogenates were incubated with various doses of antioxidants for 45 min at room temperature. After incubation, the homogenates were treated with 5 mM CH at 37 C for 15 min.
Immunodetection of eEF-2. Hepatic proteins (30 mg) were separated by sodium dodecyl sulfate 10% polyacrylamide gel electrophoresis, and were transferred to a nitrocellulose membrane (Hybond-c extra, Amersham Life Science, USA). The transfer buffer was 25 mM Bicine, 25 mM Bis-Tris, and 1 mM EDTA, pH 7.2. The power conditions were 120 V, 2 h. After the transfer, membranes were stained with Ponceau red. The amount of protein layered was controlled by quantification of three easily distinguishable bands in the Ponceau red-stained membranes. The membranes were blocked with blocking buffer (2% dry milk in 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, 0.05% Tween-20) for 1 h at room temperature. They were then incubated with polyclonal anti-eEF-2 antibody at a dilution of 1:1,000 for 3 h at room temperature. After incubation, they were washed in 20 mM Tris-HCl, pH 7.5, 500 mM NaCl, and 0.05% Tween-20, and incubated with peroxidaseconjugated anti-Rabbit immunoglobulin secondary antibodies (Dako, Produktionsvej, Denmark). The proteins were visualized using a chemiluminiscence kit (Santa Cruz Biotechnology, Santa Cruz, CA). All experiments were repeated in triplicate. The bands were analyzed by densitometry using Quantity One Ò 1-D Analysis Software (BioRad, Hercules, CA). The amount of protein layered was controlled by quantification of three easily distinguishable bands on the Ponceau red-stained membranes.
Determination of lipid hydroperoxide by oxidation of Fe
2þ in the presence of xylenol orange. Lipid hydroperoxides were measured as previously described.
14) The reagent was prepared with 100 mmol/l of xylenol orange, 4 mM butylated hydroxytoluene, 25 mM sulfuric acid, and 250 mM ammonium ferrous sulfate. The samples were mixed with 900 ml of reagent and 55 ml of methanol. After mixing, they were incubated at room temperature for 3 min. The vials were centrifuged at 2;400 Â g for 10 min. The absorbance of the supernatant was measured at 560 nm (" ¼ 4:
Spectrophotometric DNPH assay for carbonyl content determination. Carbonyl groups were determined as described by Levine et al. 15) Briefly, aliquots of liver homogenates were treated with a solution of 10 mM 2,4-dinitrophenylhydrazine (2,4-DNPH) in 2 M HCl and allowed to stand at room temperature for 1 h, with vortexing every 15 min. Proteins were precipitated with 20% trichloroacetic acid, and centrifuged at 11;000 Â g for 3 min. The protein pellets were washed 3 times with 1-ml portions of ethanol/ethyl acetate (1:1, v/v) to remove any free 2,4-DNPH. The samples were resuspended in 6 M guanidine hydrochloride in 50% formic acid overnight at room temperature. The carbonyl content was determined from the absorbance at 366 nm using a molar absorption coefficient of 22,000 M À1 cm À1 .
Protein determination. The protein content of the samples was measured by the method of Lowry, using BSA as the standard. 16) Statistical analysis. One-way analysis of variance (ANOVA) followed by Tukey's test was used to compare results.
Results
Effects on eEF-2 levels of lipoic acid, coenzyme Q10, tetrahydrofolic acid, and PBN in CH-treated homogenates
In order to induce oxidative stress in the homogenates, 5 mM CH was used. In the control samples, only a major band of eEF-2 (100 kDa) was observed in the liver homogenates (Fig. 1A) . Treatment of these homogenates with 5 mM CH caused a depletion of eEF-2. Five mM of CH was used, because in a previous study we determined that eEF-2 depletion tends to plateau.
9)
These results are not a consequence of loading different amounts of protein in the various wells as demonstrated by staining of the membrane with Ponceau red (Fig. 1B) . The optical density of the bands was quantified in nitrocellulose membranes immunostained with anti-eEF-2 antibody. Under the experimental conditions used in this study, 5 mM CH caused depletion in the eEF-2 level of 66% with respect to the control homogenate (Fig. 1C) .
To determine whether it is possible to protect eEF-2 from the effects of CH, several antioxidants were used. All of them were added to the liver homogenates. After incubation for 45 min at room temperature with the antioxidant, the homogenates were incubated with 5 mM CH for 15 min. Lipoic acid (0.01, 0.1, and 1 mM) partially prevented the decline in the levels of eEF-2 caused by CH ( Fig. 2A ). This protective effect was dose-dependent, and in all cases the differences were statistically different with respect to the CH-treated homogenates. The eEF-2 levels were 73.3% of the control when the homogenates were pre-treated with 1 mM lipoic acid. Less protection was found using 0.1 and 0.01 mM lipoic acid, but still the eEF-2 level was higher than in the CH-treated homogenates. None of the three concentrations of lipoic acid affected eEF-2 when used alone.
Three concentrations of CoQ10 were used: 0.05, 0.1, and 0.25 mM. The lowest concentration prevented to some extent the fall in eEF-2 levels after CH treatment, so that the level was 62.5% with respect to control instead of the 33% found in the CH-treated homogenates (Fig. 2B) . The higher concentrations of CoQ10 slightly increased protection further. When used alone, CoQ10 did not affect the level of eEF-2.
THF, the active form of folic acid, was used at two concentrations: 1 and 25 mM. Both concentrations were extremely effective in protecting eEF-2 (Fig. 2C) . The levels of this protein were 86 and 71% of the control values respectively, which indicates a high degree of protection against the loss caused by CH. eEF-2 levels were unaffected when the homogenates were treated only with THF.
Spin trap PBN has been used experimentally to neutralize the effects of free radicals. 17) Three concentrations of PBN were used: 1, 25, and 50 mM. After pretreatment with PBN, the levels of eEF-2 were 69, 57, and 43% of the untreated control respectively, and the effect was proportional to the dose (Fig. 2D) . Surprisingly, the two lower concentrations of PBN alone affected eEF-2, which suggests that this compound has pro-oxidant activity under some circumstances.
Effect of lipoic acid, coenzyme Q10, tetrahydrofolic acid, and PBN on lipid peroxidation caused by CH CH increased to a great extent the amount of lipid peroxides in liver homogenates (Fig. 3) , 43-fold the value found in the control. The absolute value of LP in the control homogenates was 4:21 AE 0:22 nmol/mg of proteins. Pre-incubation of the homogenates with 1 and 0.1 mM lipoic acid partially prevented this increase, the protection degree being dose-dependent. However, using 1 mM of lipoic acid, LPs were still 23.8-fold higher than those in the control. No effect was observed using 0.01 mM. It is noteworthy that lipoic acid alone increased the levels of LP significantly with respect to the control.
CoQ10 was effective in preventing part of the lipid peroxidation caused by CH. Using 0.25 mM of CoQ, the LP levels were 10-fold the level of those found in the control, which represents a substantial decrease with respect to the LP in the CH-treated homogenate. The protective effect was proportional to the concentration used. Co10Q itself did not affect lipid peroxidation.
THF treatment provided the best results in preventing the lipid peroxidation caused by CH. This is in agreement with previous results indicating the anti-lipid peroxidation properties of folic acid. 18 ) Although 1 mM of THF acid only partially prevented the formation of LP, induction of oxidative damage to lipids was totally prevented by 25 mM THF.
The protective effect of PBN was observed at the three concentrations used. However, it appeared to reach a plateau and, the LP levels remained elevated at 14-fold over the control values when 50 mM of PBN was used. PBN alone did not affect the levels of LP.
Effect of antioxidants on protein oxidation caused by CH
The carbonyl groups of proteins did not increase as much as LP after CH treatment, where the increase in CO groups was 2.6-fold with respect to the controls (Fig. 4) . The absolute value for the CO groups in the control homogenates was 5:54 AE 0:38 nmol CO/mg of proteins. Lipoic acid prevented to a great extent the increase in CO groups caused by CH. Protein oxidation in the homogenates pre-treated with lipoic acid before CH remained elevated 1.3-, 1.5-, and 2.1-fold respectively with respect to the controls (Fig. 4A) . Used alone, lipoic acid did not affect protein oxidation, except when it was used at 0.01 mM. CoQ10 partially prevented the increase in CO groups induced by CH. This effect was dose-dependent. The CO groups in the homogenate pretreated with 0.25, 0.1, and 0.05 mM CoQ10 were 1.5-, 2.0-, and 2.2-fold respectively with respect to untreated control (Fig. 4B) . No change in the CO groups was observed when CoQ10 was used alone. Pre-treatment of the homogenate with 25 mM of THF totally prevented the increase in CO groups caused by CH (Fig. 4C) . However, 1 mM of this compound did not prevent the effect of CH on the proteins. Using the two higher doses, PBN slightly protected the increase in CO groups induced by the oxidant (Fig. 4D) . No change was observed at 1 mM. It is noteworthy that PBN alone induced the CO groups even when the lower doses were used.
Discussion
Here, we have studied the in vitro protective effects of four antioxidants on eEF-2 under conditions of oxidative stress. This protein catalyzes the movement of the ribosome along the m-RNA during the translation process. It is regulated by many factors and circumstances and it has been suggested that it may have important functions besides its participation in protein synthesis. 7) This protein is also particularly sensitive to oxidative stress. 19) Many of the molecular changes that occur in it when young animals are treated with oxidant compounds are similar to those that occur during aging. 5) This suggests that the cause of inhibition of protein synthesis during aging is eEF-2 oxidation.
One of the effects of protein oxidation is direct breakdown of the polypeptide chain, [20] [21] [22] which leads to disappearance of the protein. Active oxygen species have been described as directly producing fragmentation of the polypeptide chain, probably by the peroxy radicalmediated -amidation pathway. 23) Therefore, one of the mechanisms responsible of the decrease in eEF-2 levels might be direct action of peroxy radicals generated. Also, oxygen radical-mediated oxidation of proteins is a marking step in protein degradation. This is confirmed by several observations, including the fact that many proteases degrade oxidized proteins more rapidly than unoxidized forms. 24) In a previous study, we observed that not all oxidant compounds affected eEF-2.
10) Mainly, those inducing lipid peroxidation induced changes in eEF-2, and this effect was mediated by the low molecular weight aldehydes that are formed during the process of lipid peroxidation. 9) These aldehydes, malondialdehyde and 4-hydroxynonenal, form adducts with eEF-2 in vitro and in vivo after treatment of homogenates and rats with CH. 25) Because it has been found that they affect proteolytic activities, 26) the formation of adducts can affect not only all the regulatory mechanisms of eEF-2, but also its proteolysis. There is abundant evidence that lipid peroxidation products are capable of modifying proteins and, in some cases, of breaking the protein backbone directly, resulting in protein fragmentation. 20, 21, 27) Thus lipid peroxidation products lead to oxidation and fragmentation of superoxide dismutase, 28) monoamine oxidase, 29) apolipoprotein B, 30) respiratory chain complexes, 31) and adenine nucleotide translocase. 32) Considering that the translation process is crucial to the cell and the whole organism, we studied in vitro to determine whether it is possible to protect eEF-2 subjected to oxidative stress using various antioxidants that varied in structure, solubility, and cell compartmentalization. The aim was to determine whether all antioxidants protected eEF-2 to the same extent. Each antioxidant was used at various concentrations relative to its solubility in the incubation media.
Although the concept of antioxidant refers to any molecule capable of neutralizing the effects of oxidants, the antioxidants do not always emerge in the right place at the right time in vivo. This frequently results in the imbalance between antioxidants and reactive oxygen species. Although the in vivo redox status is usually in good balance, exogenous antioxidants are expected to exert preventive effects when the balance is broken as soon as they are present. In previous studies, using a proteomics approach, we found that individual antioxidants such as folic acid are able to protect only certain proteins damaged by alcohol consumption. 13) These suggests that in the same way that oxidants do not damage the proteins in a non-specific, indiscriminate manner, antioxidants also protect only a few specific biochemical pathways. It follows that the extent of protection of a particular biological process by antioxidant molecules must to be tested by using these antioxidants one at a time.
In our case, the antioxidants lipoic acid, CoQ10, THF, and PBN were chosen because of the extensive bibliography about them and because they act at different cellular levels and differ in solubility in water and lipids. Lipoic acid, a derivative of octanoic acid, is a natural compound soluble in water and fat. It is a Results are expressed as percentages with respect to control, and are the mean AE SEM for five animals. CO groups were determined as described in ''Materials and Methods.'' a, significantly different from control (ANOVA followed by Tukey's test, p < 0:001); b, significantly different from CH-treated homogenates (ANOVA followed by Tukey's test, p < 0:001).
powerful antioxidant with metal-chelating capabilities, including Cu þ2 , and Fe þ2 . Also, it can regenerate other antioxidants, such as vitamin C and E, from their oxidized forms. 33, 34) CoQ10 is a lipophilic substance present in the hydrophobic interior of the phospholipid bilayer of virtually all cellular membranes. It is a potent antioxidant that inhibits lipid peroxidation by scavenging free radicals directly or reducing -tocopheroxyl radical to -tocopherol. 35) Also, autoxidation of its semiquinone form is the major intracellular source of superoxide and hydrogen peroxide generation. 36) THF is the active form of folic acid, whose protective effect has been identified under many physiological and pathological situations. 37, 38) PBN is a spin trap that has been primarily used experimentally. 17, 39) In general, we observed that to a greater or lesser extent all of them prevented an increase of lipid peroxides due to CH, especially THF and CQ10. In some cases treatment of the homogenate with the antioxidant alone significantly increased the amount of LP. For instance, lipoic acid per se significantly increased LP, even at the lowest concentration. The pro-oxidant activity of antioxidants is a controversial issue, because sometimes reaction with oxidants can produce other radicals that might propagate a radical chain reaction and oxidative damage to cells. 40) A prooxidant action in certain circumstances at certain concentrations has been found for lipoic acid. 33, 41, 42) This potential dual effect makes it difficult to achieve a protective effect when used in combination with other antioxidants.
Regarding CO groups, the results showed variability between antioxidants in preventing an increase after treatment with CH. Again, the most effective antioxidant in preventing this increase was THF; CO groups in the liver homogenate pre-treated with THF were even lower than controls. CoQ10 did not totally forestall the effect of CH on protein oxidation. Although CoQ10 has been described as being able to act both as a pro-oxidant and an antioxidant, 35) in our study no pro-oxidant activity was observed.
In the case of lipoic acid, when used alone, the lowest concentration increased the levels of the CO groups. An oxidant effect for low doses compared with higher doses has been described for vitamin C, 43) but PBN not only did not prevent the effect of CH, but by itself increased protein oxidation at all concentrations used.
These results indicate that each antioxidant has a different capacity to fight biomolecule oxidation, which depends on many factors, such as chemical structure, the ability to arrive at a given site in the cell, the stability of the free radical formed in the molecule, molecular interactions within the homogenate, etc.
In theory, a potential limitation of some antioxidants in protecting against lipid peroxidation is solubility on the lipidic parts of the cell. Our results indicate that folic acid is able to prevent the formation of LP although folic acid is a water soluble compound. This might be due to the fact that the toxicity of lipid peroxidation goes beyond the site of LP origin and is translocated to subcellular sites. 44) Therefore, THF plays a role in preventing such propagation. The great anti-lipid peroxidation capacity of folic acid has been described as comparable to that of vitamin E.
18)
The antioxidants also prevented a loss of eEF-2 due to CH, but this effect varied depending on the antioxidant used. Whereas THF had a higher protective effect, PBN affected the levels of eEF-2 by itself. Nevertheless, the action of protective compounds might have been facilitated by the fact that the experimental model is a homogenate, where the molecules were not confined to a particular place.
Since all of the antioxidants had partially inhibitory effects, we investigated the effect of a combination of these antioxidants (using the lower concentration), but complete protection was not achieved (results not shown), which suggests that all of them act through the same mechanism. Clearly, it is necessary to distinguish between a general antioxidant effect and a protective effect on specific proteins. The fact that an antioxidant protects one protein does not mean that it protects the rest. It has been found that folic acid administered along with ethanol does not protect all the proteins that are altered by alcohol consumption, 13) but only prevents the loss of a few of them. The physiological relevance of antioxidant treatment depends on the importance of the protected pathway. Although none of the antioxidants achieved full protection from the decline in the levels of eEF-2, the partial effect represents an advantage in terms of physiological consequences with respect to the situation in which there is no antioxidant at all because part of the translation process can be preserved.
Our results indicate that folic acid was the most effective not only in protecting eEF-2 but also in preventing the induction of LP by CH. One mM of THF started to prevent the effects of CH on LP and the CO groups, and so the effective doses are within these two concentrations. In previous work in our laboratory we discussed the importance of lipid peroxidation on alteration of eEF-2. The effect appears to be mediated via low molecular weight aldehydes that occur after lipid peroxidation. This suggests that folic acid in combination with vitamin E, which also prevents lipid peroxidation, but in the lipidic sites inside the cell, would be a good antioxidant combination to protect eEF-2 as much as possible and to protect the process of translation. In addition, if each antioxidant protects only a few metabolic pathways, even using a combination of all of them, one would still be far from protecting all the biochemical pathways that decline with age. Maybe this is one of the causes due to which antioxidants are not effective in preventing the loss of all physiological functions that occurs during aging and this is due to the specific action of antioxidants.
On the other hand, one must keep in mind that while these antioxidants may protect against oxidation of specific molecules, they are not always available to protect them from all endogenous and exogenous oxidants present in the body. As described previously, 45) oxidative stress changes throughout the day, and ideally one would have to make sure that antioxidants are present in adequate quantities as long as possible.
Our experiments were performed with high concentrations of the antioxidant, which is not achieved in vivo even with an optimum intake of the vitamin. In addition, it is true that the oxidative stress induced by 5 mM of CH may be high as compared to the normal physiological levels of exposure to endogenous and exogenous oxidative factors. Our aim was simply to produce observable effects on eEF-2. The question is whether a protective concentration can be reached inside the cells when these compounds are given orally.
In conclusion, in order to protect the translation process during aging, the antioxidant must be effective in preventing lipid peroxidation preferentially. According to our results, THF is the best choice. However, the use of a particular antioxidant to protect a particular biochemical pathway does not imply that intake of this antioxidant protects all biomolecules, since its phyisiological effect depends on the relevance of the protected enzymes. The challenge is to design a good combination of actual antioxidants in order to protect the maximum number of biochemical pathways that are responsible for tissue decline with aging. Work is underway to determine whether this phenomenon is present in living cells.
